Lipid panel
Measures total cholesterol, LDL cholesterol (LDL-C), HDL cholesterol (HDL-C) and triglycerides to assess cardiovascular risk. Whether treatment is needed depends on overall risk, taking in age, blood pressure, blood sugar, smoking and other factors.
Preparation: Usually no fasting needed. If your triglycerides come back high, your doctor may ask for a repeat test after fasting.
When it is worth testing
- Every 4–6 years for adults from age 20, and more often with age or risk factors (American Heart Association). In the UK, the NHS Health Check includes it every 5 years from age 40 to 74.
- People with cardiovascular disease, diabetes, high blood pressure or obesity, smokers, and people with a family history of premature cardiovascular disease
- Before and after starting lipid-lowering measures, to assess the effect
- Consider rechecking LDL-C while taking pterostilbene
Common cut-offs
| Borderline high LDL-C | 130–159 mg/dL (3.4–4.1 mmol/L) |
|---|---|
| High LDL-C | ≥ 160 mg/dL (≥ 4.1 mmol/L) |
| Borderline high triglycerides | 150–199 mg/dL (1.7–2.3 mmol/L) |
| High triglycerides | ≥ 200 mg/dL (≥ 2.3 mmol/L) |
| Low HDL-C | < 40 mg/dL (< 1.0 mmol/L) |
Related supplements
High-potency omega-3 (EPA/DHA, SPM precursors) Recheck while taking
When fish oil is used to help lower triglycerides, recheck the lipid panel after about 2 months to see the effect. The evidence for high-dose prescription-strength fish oil (4 g/day) cannot be applied directly to ordinary doses.
Pterostilbene Recheck while taking
A small trial found that pterostilbene taken alone (100–250 mg/day) raised LDL-C. People with cardiovascular risk should have their lipids rechecked about 2 months after starting it.
Immediate-release niacin (vitamin B3) Recheck while taking
When niacin is used under medical supervision to adjust blood lipids, recheck the lipid panel to see the effect.
Notes
- These cutoffs apply to primary prevention in low-risk people. People at high risk have lower LDL-C targets, so follow your doctor’s advice.
- Triglycerides are strongly affected by recent eating and drinking.
- HDL-C is a risk marker, not a target to “raise” with supplements.
References (4)
- Li 2023 · J Geriatr Cardiol · Guideline, review or authoritative source — 2023 China Guidelines for Lipid Management
- Skulas-Ray 2019 · Circulation · Guideline, review or authoritative source — Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- Riche 2014 · Evid Based Complement Alternat Med · RCT · n=80 — Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial
- Lupin Pharmaceuticals, Inc. 2023 · DailyMed, National Library of Medicine · Guideline, review or authoritative source — NIACIN tablet, extended release: prescribing information